|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.76 USD | +1.13% |
|
+0.11% | +7.42% |
| 08:52am | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| Jul. 21 | Gilead Sciences Shares Fall After Downgrade From Leerink Partners | MT |
| Market Cap | 162B 142B 132B 121B 228B 15,608B 231B 1,567B 613B 7,637B 607B 594B 26,383B | P/E 2026 * |
-46.9x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 171B 150B 139B 128B 241B 16,521B 245B 1,659B 649B 8,084B 643B 629B 27,926B | EV / Sales 2026 * |
5.62x | EV / Sales 2027 * | 5x |
| Free-Float |
99.88% | Yield 2026 * |
2.53% | Yield 2027 * | 2.62% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +1.06% | ||
| 1 week | -0.14% | ||
| Current month | +4.09% | ||
| 1 month | +5.32% | ||
| 3 months | -1.05% | ||
| 6 months | +0.28% | ||
| Current year | +7.15% |
| 1 week | 129.13 |  | 140.61 |
| 1 month | 123.67 | | 140.61 |
| Current year | 116.88 | | 157.29 |
| 1 year | 108.46 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/15/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% | ||
| 7/15/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 7/1/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.04% | -0.14% | +19.37% | +69.34% | 162B | |
| -1.10% | +0.64% | +49.91% | +153.42% | 1,048B | |
| +1.70% | +3.59% | +52.38% | +49.57% | 603B | |
| -0.44% | +4.65% | +36.53% | +78.43% | 452B | |
| -0.42% | +0.67% | +30.81% | +21.54% | 327B | |
| -0.16% | +2.74% | +36.02% | +38.04% | 283B | |
| +1.68% | +1.08% | +22.70% | +17.83% | 259B | |
| -1.40% | -3.34% | -24.63% | -41.91% | 219B | |
| +0.28% | +2.63% | +20.30% | +56.20% | 198B | |
| -0.10% | +0.54% | -0.74% | -33.47% | 142B | |
| Average | +0.11% | +1.85% | +24.27% | +40.90% | 369.38B | |
| Weighted average by Cap. | -0.05% | +1.73% | +34.72% | +69.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.46B 26.69B 24.78B 22.77B 42.91B 2,939B 43.54B 295B 116B 1,438B 114B 112B 4,969B | 32.32B 28.32B 26.29B 24.16B 45.52B 3,119B 46.19B 313B 123B 1,526B 121B 119B 5,272B |
| Net income | -3.39B -2.97B -2.76B -2.53B -4.78B -327B -4.85B -32.86B -12.86B -160B -12.73B -12.46B -553B | 9.76B 8.55B 7.94B 7.3B 13.75B 942B 13.95B 94.59B 37.02B 461B 36.64B 35.86B 1,592B |
| Net Debt | 9.46B 8.29B 7.7B 7.07B 13.32B 913B 13.52B 91.67B 35.88B 447B 35.51B 34.75B 1,543B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | $131.85 | +1.21% | 1,690,423 |
| 26-07-21 | $130.28 | -2.20% | 8,371,109 |
| 26-07-20 | $133.21 | -0.80% | 4,103,979 |
| 26-07-17 | $134.28 | -1.48% | 6,903,235 |
| 26-07-16 | $136.30 | +3.49% | 7,926,819 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
